Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINCOMYCIN vs LISDEXAMFETAMINE DIMESYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINCOMYCIN vs LISDEXAMFETAMINE DIMESYLATE: Safety Overview

Metric LINCOMYCIN LISDEXAMFETAMINE DIMESYLATE
Total FAERS Reports 210 17,054
Deaths Reported 21 122
Death Rate 10.0% 0.7%
Hospitalizations 37 2,028
Average Patient Age 46.3 yrs 27.0 yrs
% Female Patients 69.3% 54.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Aug 25, 2023
Manufacturer Pharmacia & Upjohn Company LLC Rhodes Pharmaceuticals
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Prescription